Camurus AB (CAMRF)
58.00
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Camurus Debt to Equity Ratio : 0.0249 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.0249 |
| December 31, 2025 | 0.025 |
| September 30, 2025 | 0.0258 |
| June 30, 2025 | 0.0268 |
| March 31, 2025 | 0.0306 |
| December 31, 2024 | 0.0052 |
| September 30, 2024 | 0.0059 |
| June 30, 2024 | 0.0072 |
| March 31, 2024 | 0.0086 |
| December 31, 2023 | 0.0164 |
| September 30, 2023 | 0.017 |
| June 30, 2023 | 0.0194 |
| March 31, 2023 | 0.0226 |
| December 31, 2022 | 0.0264 |
| September 30, 2022 | 0.026 |
| June 30, 2022 | 0.0251 |
| March 31, 2022 | 0.0281 |
| December 31, 2021 | 0.0302 |
| September 30, 2021 | 0.032 |
| June 30, 2021 | 0.028 |
| March 31, 2021 | 0.0293 |
| December 31, 2020 | 0.0301 |
| September 30, 2020 | 0.0288 |
| June 30, 2020 | 0.0458 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.046 |
| December 31, 2019 | 0.0433 |
| September 30, 2019 | 0.0627 |
| June 30, 2019 | 0.0563 |
| March 31, 2019 | 0.0496 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Orexo AB | 0.0192 |
| Swedencare AB | 0.253 |
| Moberg Pharma AB | 0.0032 |
| Infant Bacterial Therapeutics AB | 0.00 |
| Eli Lilly & Co. | 1.390 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 520.47M |
| Total Liabilities (Quarterly) | 56.25M |
| Shareholders Equity (Quarterly) | 464.22M |
| Current Ratio | 11.57 |
| Net Debt Paydown Yield | -0.06% |